Natriumchlorid Braun (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumchlorid Braun, is an electrolyte presented as an injection solution for intravenous use. It is employed to restore extracellular sodium and chloride levels and to expand intravascular volume in patients with hypovolemia, electrolyte imbalance, or dehydration.

GNH USA supplies Natriumchlorid Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company provides regulatory‑approved bulk and packaged product to procurement teams, ensuring reliable delivery across global markets. All shipments comply with EU quality standards and are accompanied by full documentation for customs clearance.

Natriumchlorid Braun is used in the management of fluid and electrolyte disorders, acting to correct sodium and chloride deficits. - Hypovolemia: restores circulating blood volume, improves hemodynamic stability, and enhances tissue perfusion during acute fluid loss. - Electrolyte imbalance: normalizes extracellular sodium and chloride concentrations, helping to correct hyponatremia or hypochloremia. - Dehydration: provides rapid rehydration, supports cellular metabolism, and assists in maintaining acid‑base balance.

Intravenous sodium chloride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Hypernatremia: elevated serum sodium levels causing thirst or confusion. - Hyperchloremia: increased chloride leading to metabolic acidosis. - Phlebitis: inflammation at the infusion site. - Fluid overload: swelling or pulmonary edema in susceptible patients. - Electrolyte shifts: transient changes in potassium or calcium levels. - Local irritation: pain or burning sensation at injection site.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis with rash, bronchospasm, or hypotension. - Cardiac arrhythmia: irregular heart rhythm due to electrolyte disturbances. - Renal impairment: worsening kidney function in patients with pre‑existing disease. - Hemolysis: destruction of red blood cells in rare cases. - Septicemia: bloodstream infection if aseptic technique is breached.

When using Natriumchlorid Braun, clinicians should observe specific precautions to minimize risks and ensure optimal therapy. - Indication assessment: verify the presence of hypovolemia or electrolyte deficit before administration. - Rate of infusion: adjust infusion speed according to patient volume status and cardiac function. - Monitoring: regularly check serum sodium, chloride, and fluid balance during therapy. - Contraindications: avoid use in patients with known hypersensitivity to sodium chloride solutions. - Compatibility: ensure solution compatibility with other IV drugs and line materials. - Storage: Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Sodium chloride injection can interact with other medications, affecting electrolyte balance or infusion compatibility.

Major Interactions (Avoid): - Loop diuretics: may exacerbate sodium loss and require higher saline volumes. - ACE inhibitors/ARBs: can potentiate hyperkalemia when combined with high‑chloride loads. - Hypertonic glucose solutions: risk of precipitation when mixed with saline.

Moderate Interactions (Monitor Closely): - Calcium‑containing solutions: may form calcium chloride precipitate if mixed directly. - Blood products: concurrent infusion can alter electrolyte measurements; separate lines are recommended. - Certain antibiotics (e.g., aminoglycosides): monitor renal function as saline may affect drug clearance.